Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Targeted Radionuclide Therapy: A Historical and Personal Review.
Journal: Seminars in nuclear medicine
Published: December 18, 2019
Less is More: The Impact of Multidisciplinary Thyroid Conference on the Treatment of Well-Differentiated Thyroid Carcinoma.
Journal: World journal of surgery
Published: October 24, 2017
Phase 1 Study of High-Specific-Activity I-131 MIBG for Metastatic and/or Recurrent Pheochromocytoma or Paraganglioma.
Journal: The Journal of clinical endocrinology and metabolism
Published: September 12, 2017
Radioactive Iodine Therapy of Differentiated Thyroid Carcinoma: Redesigning the Paradigm.
Journal: Molecular imaging and radionuclide therapy
Published: January 25, 2017
Use of radiopharmaceuticals in diagnostic nuclear medicine in the United States: 1960-2010.
Journal: Health physics
Published: March 27, 2015
(90)Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 21, 2015
Multiple myeloma: 18F-FDG-PET/CT and diagnostic imaging.
Journal: Seminars in nuclear medicine
Published: December 06, 2014
Guest editorial: Skeletal nuclear medicine.
Journal: Seminars in nuclear medicine
Published: December 06, 2014
Radioimmunotherapy of Metastatic Prostate Cancer with ¹⁷⁷Lu-DOTAhuJ591 Anti Prostate Specific Membrane Antigen Specific Monoclonal Antibody.
Journal: Current radiopharmaceuticals
Published: November 21, 2014
99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen: pharmacokinetics and biodistribution studies in healthy subjects and patients with metastatic prostate cancer.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: October 25, 2014
Last Updated: 09/26/2026